Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca;Traitement du lymphome de Burkitt de l'enfant par le protocole LMB89 à Casablanca

Bulletin du Cancer

Volumn 92, Issue 2, 2005, Pages 193-198

  Madani, Abdellah ^a   Benhmiddoune, Leila ^a   Zafad, Saadia ^a   Harif, M'Hamed ^a   Quessar, Asmaa ^a   Benchekroun, Said ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

Author keywords

Burkitt lymphoma; Chemotherapy; Child

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; HYDROCORTISONE; LMB89 PROTOCOL; METHOTREXATE; PREDNISONE; VINCRISTINE;

ABDOMINAL TUMOR; ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPOKALEMIA; INFANT; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MAXILLA TUMOR; NEUROTOXICITY; PROGNOSIS; SIDE EFFECT; THROMBOCYTOPENIA; MORTALITY; PRESCHOOL CHILD; RECURRENT DISEASE; REMISSION; SURVIVAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; HYDROCORTISONE; INFANT; LEUCOVORIN; MALE; METHOTREXATE; PREDNISONE; RECURRENCE; REMISSION INDUCTION; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 14544301431     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sandlund JT, Downing JR, Ctist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996; 334: 1238-48.
2. Plo KJ. Burkitt lymphoma in the Côte d'Ivoire from 1966 to 1995: a progress report. Med Pediatr Oncol 2000; 34: 206-9.
3. Wright DH. What is Burkitt's lymphoma and when is it endemic? Blood 1999; 93: 758-9.
4. Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, et al. The Société Française d'Oncologie Pédiatrique LMB 89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001; 97: 3370-9.
5. Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfort-Münster group trial NHL-BFM 90. Blood 1999; 94: 3294-306.
6. Murphy SE. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarties from lymphomas in adults. Semin Oncol 1980; 7: 332-9.
7. Yaniv I, Fischer S, Mor C, Stark B, Goshen Y, Stein J, et al. Improved outcome in childhood B-cell lymphoma with the intensified french LMB protocol. Med Pediatr Oncol 2000; 35: 8-12.
8. Mottl H, Bajciova V, Nemec J, Al Shemmari S, Al Awadi S. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait. Pediatr Hematol Oncol 2003; 20: 103-10.
9. Chantada GL, Felice MS, Zubizarreta PA, Diaz L, Gallo G, Sackmann-Muriel F. Results of a BFM-based protocol for the treatment of childhood B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukemia in Argentina. Med Pediatr Oncol 1997; 28: 333-41.
10. Chao TY, Wang TY, Lee WH. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan. Cancer 1997; 80: 121-8.
11. Kavan P, Kabickova E, Gajdos P, Koutecky J. Treatment of pediatric B-cell non Hodgkin's lymphomas at the Motol hospital in Prague, Czech republic: Results based on the NHL BFM 90 protocols. Pediatr Hematol Oncol 1999; 16: 201-12.
12. D'khissy M. Le lymphome de Burkitt (54 cas). Thèse de médecine, Casablanca, Maroc, 1992, n° 252.
13. Wessels G, Hesseling PB. High-dose intense chemotherapy in south african children With B-cell lymphoma: morbidity, supportive measures and outcome. Med Pediatr Oncol 2000; 34: 143-6.
14. Vannier JP, Patte C, Philip T, Zucket JM, Gentet JC, Lamagniere JP, et al. Traitement des lymphomes B étendus de l'enfant: Études de la Société Française d'Oncologie Pédiatrique. Bull Cancer 1988; 75: 61-8.
15. Atra A, Imesson JD, Hobson R, Gerrard M, Hann IM, Eden OB, et al. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol. Br J Cancer 2000; 82: 1396-402.
16. Spreafico F, Massimino M, Luksch R, Casanova M, Cefalo GS, Collini P, et al. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children. J Clin Oncol 2002; 20: 2783-8.
17. Gururangan S, Sposto R, Cairo MS, Meadows AT, Finlay JL. Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group Study. J Clin Oncol 2000; 18: 2017-25.
18. Lemerle J, Msefer-Alaoui F, Harif M, Kogumu E, Ladjadj Y, Moreira C, et al. Peut-on traiter les cancers des enfants en Afrique? L'action du Groupe franco-africain d'oncologie pédiatrique. Médecine Thérapeutique Pédiatrie 2003; 3: 192-7.